Concepts (204)
Concepts are derived automatically from a person's publications.
In this concept 'cloud', the sizes of the concepts are based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the same topic. The largest concepts are those that are most unique to this person.
- A549 Cells
- Adenocarcinoma
- Administration, Oral
- Adult
- Aged
- Aged, 80 and over
- Albumins
- Aneuploidy
- Animals
- Antibodies, Monoclonal
- Antibodies, Monoclonal, Humanized
- Anticoagulants
- Antigens, CD
- Antigens, Differentiation, Myelomonocytic
- Anti-Inflammatory Agents
- Antineoplastic Agents
- Antineoplastic Agents, Immunological
- Antineoplastic Combined Chemotherapy Protocols
- Atherosclerosis
- B7 Antigens
- B7-H1 Antigen
- Betacoronavirus
- Biomarkers
- Biomarkers, Tumor
- Blood Coagulation
- Blood Proteins
- Body Mass Index
- Brain
- Brain Neoplasms
- Breast Neoplasms
- Cancer Survivors
- Capecitabine
- Carboplatin
- Carcinogenesis
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Squamous Cell
- Cardiotoxicity
- Catheter Ablation
- Cause of Death
- CD8-Positive T-Lymphocytes
- Cell Count
- Cell Line, Tumor
- Centromere
- Chemoradiotherapy
- Chemotherapy, Adjuvant
- Chi-Square Distribution
- Chromosome Duplication
- Chromosomes, Human, Pair 7
- Cohort Studies
- Colchicine
- Colorectal Neoplasms
- Combined Modality Therapy
- Connecticut
- Coronavirus Infections
- Costs and Cost Analysis
- C-Reactive Protein
- Datasets as Topic
- Delivery of Health Care
- Diabetes Mellitus
- Diarrhea
- Diet
- Disease Progression
- Disease-Free Survival
- Disseminated Intravascular Coagulation
- Dose-Response Relationship, Drug
- Drug Resistance, Neoplasm
- ErbB Receptors
- Erlotinib Hydrochloride
- Evaluation Studies as Topic
- Everolimus
- Exercise
- Female
- Fibrin Fibrinogen Degradation Products
- Fibrinolytic Agents
- Fluorescent Antibody Technique
- Follow-Up Studies
- Gene Amplification
- Gene Expression Regulation, Neoplastic
- Genes, erbB
- Genotype
- Geography
- GRB2 Adaptor Protein
- Greece
- Health Resources
- Hematologic Neoplasms
- Hematologic Tests
- Hemorrhage
- Heparin, Low-Molecular-Weight
- Hepatitis A Virus Cellular Receptor 2
- Hospital Mortality
- Hospitalization
- HT29 Cells
- Humans
- Hydroxymethylglutaryl-CoA Reductase Inhibitors
- Hypertension, Pulmonary
- Immunohistochemistry
- Immunologic Factors
- Immunosuppressive Agents
- Immunotherapy
- In Situ Hybridization
- In Situ Hybridization, Fluorescence
- Incidence
| - Inflammation
- Injections, Subcutaneous
- Inpatients
- Interleukin 1 Receptor Antagonist Protein
- Interleukin-10
- Interleukin-6
- Ipilimumab
- Kaplan-Meier Estimate
- Liver Neoplasms
- Lung
- Lung Neoplasms
- Lymphocyte Activation
- Lymphocytes, Tumor-Infiltrating
- Lysophospholipids
- Male
- Mass Spectrometry
- MCF-7 Cells
- Membrane Proteins
- Mice
- Microwaves
- Middle Aged
- Mortality
- Multivariate Analysis
- Mutation
- Neoplasm Staging
- Neoplasms
- Neoplasms, Experimental
- Neoplastic Cells, Circulating
- Obesity
- Organoplatinum Compounds
- Paclitaxel
- Pandemics
- Paraffin Embedding
- Patient Acceptance of Health Care
- Perception
- Personal Protective Equipment
- Phosphatidate Phosphatase
- Phosphoric Diester Hydrolases
- Platelet Transfusion
- Platinum Compounds
- Pneumonectomy
- Pneumonia, Viral
- Postoperative Complications
- Predictive Value of Tests
- Prevalence
- Prognosis
- Programmed Cell Death 1 Receptor
- Proportional Hazards Models
- Prospective Studies
- Protein Kinase Inhibitors
- Protein Kinases
- Proteins
- Proteomics
- Pulmonary Embolism
- Quality of Life
- Quinazolines
- Receptors, Cell Surface
- Receptors, Lysophosphatidic Acid
- Receptors, Urokinase Plasminogen Activator
- Registries
- Reproducibility of Results
- Respiration, Artificial
- Respiratory Insufficiency
- Response Evaluation Criteria in Solid Tumors
- Retreatment
- Retrospective Studies
- Risk Assessment
- Risk Factors
- RNA, Messenger
- ROC Curve
- Sarcoidosis
- Secondary Prevention
- Sensitivity and Specificity
- Signal Transduction
- Single-Cell Analysis
- Sleep Wake Disorders
- Small Cell Lung Carcinoma
- Smoking
- Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
- Standard of Care
- Survival Analysis
- Survival Rate
- Taxoids
- Telemedicine
- Thrombocytopenia
- Thrombophilia
- Thrombosis
- Time Factors
- Tissue Array Analysis
- Tissue Fixation
- Topotecan
- TOR Serine-Threonine Kinases
- Treatment Outcome
- Troponin
- Tubulin Modulators
- Tumor Suppressor Protein p53
- Urethane
- Venous Thromboembolism
- Venous Thrombosis
- Vitamin K
- V-Set Domain-Containing T-Cell Activation Inhibitor 1
- Young Adult
|
Syrigos's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(204)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(170)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_